Studies have demonstrated a correlation between CTLA-4 expression and the survival rate of cancer patients, including those with non-small cell lung cancer (NSCLC), suggesting its potential as a prognostic marker in cancer treatment [107]. This evidence concerns the gene CTLA4 and non-small cell lung carcinoma.